{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:27:53Z","timestamp":1789475273763,"version":"build-2803163510"},"reference-count":63,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,6,25]]},"abstract":"<jats:p>Background: Dementia with Lewy bodies (DLB) presents with various symptoms, posing challenges for early diagnosis challenging. Dopamine transporter (123I-FP-CIT) single-photon emission tomography (SPECT) and 123I-meta-iodobenzylguanidine (123I-MIBG) imaging are crucial diagnostic biomarkers. Hypothesis about body- and brain-first subtypes of DLB indicate that some DLB may show normal 123I-FP-CIT or 123I-MIBG results; but the characteristic expression of these two subtypes remains unclear. Objective: This study aimed to evaluate the diagnostic sensitivity of 123I-FP-CIT and 123I-MIBG imaging alone, combined in patients with DLB and explore symptoms associated with the abnormal imaging results. Methods: Demographic data, clinical status, and imaging results were retrospectively collected from patients diagnosed with possible DLB. Both images were quantified using semi-automated software, and the sensitivity of each imaging modality and their combination was calculated. Demographic data, cognition, and motor and non-motor symptoms were compared among the subgroups based on the imaging results. Symptoms related to each imaging abnormality were examined using binomial logistic regression analyses. Results: Among 114 patients with DLB, 80 underwent 123I-FP-CIT SPECT (sensitivity: 80.3%), 83 underwent 123I-MIBG imaging (68.2%), and 66 both (sensitivity of either abnormal result: 93.9%). Visual hallucinations differed among the four subgroups based on imaging results. Additionally, nocturia and orthostatic hypotension differed between abnormal and normal 123I-MIBG images. Conclusions: Overall, 123I-FP-CIT SPECT was slightly higher sensitivity than 123I-MIBG imaging, with combined imaging increasing diagnostic sensitivity. Normal results of a single imaging test may not refute DLB. Autonomic symptoms may lead to abnormal 123I-MIBG scintigraphy findings indicating body-first subtype of patients with DLB.<\/jats:p>","DOI":"10.3233\/jad-231395","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:57:14Z","timestamp":1717509434000},"page":"127-137","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies"],"prefix":"10.1177","volume":"100","author":[{"given":"Zhihui","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yume","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Kitayama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Kashiwado","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iimori","sequence":"additional","affiliation":[{"name":"Department of Radiology, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-231395_ref1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: A systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-231395_ref2","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/brain\/awab201","article-title":"Karyopherin abnormalities in neurodegenerative proteinopathies","volume":"144","author":"Pasha","year":"2021","journal-title":"Brain"},{"key":"10.3233\/JAD-231395_ref3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40266-018-00636-7","article-title":"Pharmacological management of dementia with Lewy bodies","volume":"36","author":"Hershey","year":"2019","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-231395_ref4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-231395_ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","article-title":"Clinical prevalence of Lewy body dementia","volume":"10","author":"Kane","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-231395_ref6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-231395_ref7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","article-title":"The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism","volume":"28","author":"Booij","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.3233\/JAD-231395_ref8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-231395_ref9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","article-title":"Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison","volume":"62","author":"Walker","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-231395_ref10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: Complementary or alternative techniques?","volume":"24","author":"Treglia","year":"2014","journal-title":"J Neuroimaging"},{"key":"10.3233\/JAD-231395_ref11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40336-013-0034-y","article-title":"Molecular imaging in heart failure patients","volume":"1","author":"Tamaki","year":"2013","journal-title":"Clin Transl Imaging"},{"key":"10.3233\/JAD-231395_ref12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-020-02233-8","article-title":"Lewy pathology of the esophagus correlates with the progression of Lewy body disease: A Japanese cohort study of autopsy cases","volume":"141","author":"Tanei","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-231395_ref13","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.3390\/ijms23126371","article-title":"Biomarkers of dementia with Lewy bodies: Differential diagnostic with Alzheimer\u2019s disease","volume":"23","author":"Bousiges","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-231395_ref14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00259-005-1921-x","article-title":"Comparative value of brain perfusion SPECT and [123I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"33","author":"Hanyu","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref15","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00259-020-05168-0","article-title":"A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: An investigation using the classification and regression tree analysis","volume":"48","author":"Iwabuchi","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13550-019-0477-x","article-title":"Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: Comparison of different volume of interest settings","volume":"9","author":"Iwabuchi","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.3233\/JAD-231395_ref17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00259-016-3496-0","article-title":"Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT","volume":"44","author":"Yokoyama","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref18","first-page":"1334","article-title":"Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the fischer 344 rat","volume":"288","author":"Hebert","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-231395_ref19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00259-018-3976-5","article-title":"Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT","volume":"45","author":"Matsuda","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref20","first-page":"1099","article-title":"Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson\u2019s disease and dementia with Lewy bodies","volume":"47","author":"Kashihara","year":"2006","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-231395_ref21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12149-011-0490-2","article-title":"Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: Correlation with clinical features","volume":"25","author":"Uchiyama","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.3233\/JAD-231395_ref22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fneur.2019.00152","article-title":"Cardiac 123I-MIBG scintigraphy in neurodegenerative Parkinson syndromes: Performance and pitfalls in clinical practice","volume":"10","author":"Skowronek","year":"2019","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-231395_ref23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12350-014-9916-2","article-title":"Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations","volume":"21","author":"Nakajima","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.3233\/JAD-231395_ref24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fnins.2019.00552","article-title":"Prion-like mechanisms in Parkinson\u2019s disease","volume":"13","author":"Ma","year":"2019","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-231395_ref25","doi-asserted-by":"crossref","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","article-title":"Neuropathological evidence of body-first vs. brain-first Lewy body disease","volume":"161","author":"Borghammer","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-231395_ref26","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson\u2019s disease: A multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"issue":"Suppl 3","key":"10.3233\/JAD-231395_ref27","first-page":"III\/1-5","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J Neurol"},{"key":"10.3233\/JAD-231395_ref28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-231395_ref29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12877-021-02471-9","article-title":"Cognitive function assessed by Mini-mental state examination and risk of all-cause mortality: A community-based prospective cohort study","volume":"21","author":"Su","year":"2021","journal-title":"BMC Geriatr"},{"key":"10.3233\/JAD-231395_ref30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The Unified Parkinson\u2019s Disease Rating Scale (UPDRS): Status and recommendations","volume":"18","author":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease","year":"2003","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-231395_ref31","first-page":"307","article-title":"Guidelines\u2013Rome III diagnostic criteria for functional gastrointestinal disorders","volume":"15","author":"Rome","year":"2006","journal-title":"Liver Dis"},{"key":"10.3233\/JAD-231395_ref32","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/nau.23032","article-title":"ICI-RS 2015-Is a better understanding of sleep the key in managing nocturia?","volume":"37","author":"Denys","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.3233\/JAD-231395_ref33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J Neurol"},{"key":"10.3233\/JAD-231395_ref34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mds.25037","article-title":"A single-question screen for rapid eye movement sleep behavior disorder: A multicenter validation study","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-231395_ref35","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","article-title":"Quantification of [123I]FP-CIT SPECT brain images: An accurate technique for measurement of the specific binding ratio","volume":"33","author":"Tossici-Bolt","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref36","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.6009\/jjrt.2015_JSRT_71.12.1209","article-title":"[Comparison of Quantitative Value of Dopamine Transporter Scintigraphy Calculated from Different Analytical Software]","volume":"71","author":"Miyai","year":"2015","journal-title":"Nihon Hoshasen Gijutsu Gakkai Zasshi"},{"key":"10.3233\/JAD-231395_ref37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s12350-018-1394-5","article-title":"How do we establish cardiac sympathetic nervous system imaging with 123I-mIBG in clinical practice? Perspectives and lessons from Japan and the US","volume":"26","author":"Travin","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.3233\/JAD-231395_ref38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12350-010-9313-4","article-title":"Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging","volume":"18","author":"Okuda","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.3233\/JAD-231395_ref39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MNM.0000000000000271","article-title":"Comparison of the diagnostic performance of H\/M ratio between early and delayed phases for Lewy body disease","volume":"36","author":"Maruyama","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.3233\/JAD-231395_ref40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12149-016-1065-z","article-title":"Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database","volume":"30","author":"Nakajima","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.3233\/JAD-231395_ref41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","article-title":"Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer\u2019s disease","volume":"43","author":"Shimizu","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-1331.2007.02001.x","article-title":"(99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson\u2019s disease patients: A correlation with neuropsychological tests","volume":"15","author":"Chang","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-231395_ref43","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s00259-019-04480-8","article-title":"Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: An updated systematic review and Bayesian latent class model meta-analysis","volume":"47","author":"Nihashi","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref44","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","article-title":"[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies","volume":"43","author":"van der Zande","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-231395_ref45","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/cells8080872","article-title":"Molecular imaging of the dopamine transporter","volume":"8","author":"Palermo","year":"2019","journal-title":"Cells"},{"key":"10.3233\/JAD-231395_ref46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13195-022-01037-0","article-title":"Prodromal characteristics of dementia with Lewy bodies: ine results of the MEMENTO memory clinics nationwide cohort","volume":"14","author":"Blanc","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-231395_ref47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mds.26327","article-title":"Loss of dopamine transporter binding and clinical symptoms in dementia with Lewy bodies","volume":"31","author":"Siepel","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-231395_ref48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12149-017-1166-3","article-title":"Correlation between clinical symptoms and striatal DAT uptake in patients with DLB","volume":"31","author":"Shimizu","year":"2017","journal-title":"Ann Nucl Med"},{"key":"10.3233\/JAD-231395_ref49","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2967\/jnumed.112.114025","article-title":"Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies","volume":"54","author":"Ziebell","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-231395_ref50","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.22702","article-title":"Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I-FP-CIT SPECT study","volume":"24","author":"Roselli","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-231395_ref51","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","article-title":"The role of levodopa in the management of dementia with Lewy bodies","volume":"76","author":"Molloy","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-231395_ref52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s10020-021-00301-7","article-title":"Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson\u2019s disease","volume":"27","author":"Hirano","year":"2021","journal-title":"Mol Med"},{"key":"10.3233\/JAD-231395_ref53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.31083\/j.jin2201018","article-title":"Striatal subregion analysis associated with REM sleep behavior disorder in Parkinson\u2019s disease","volume":"22","author":"Kwak","year":"2023","journal-title":"J Integr Neurosci"},{"key":"10.3233\/JAD-231395_ref54","doi-asserted-by":"crossref","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","article-title":"Autopsy validation of the diagnostic accuracy of 123I-Metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease","volume":"98","author":"Matsubara","year":"2022","journal-title":"Neurology"},{"key":"10.3233\/JAD-231395_ref55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/ene.14240","article-title":"Clinical and pathological features affecting cardiac sympathetic denervation in autopsy-confirmed dementia with Lewy bodies","volume":"27","author":"Takahashi","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-231395_ref56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pscychresns.2009.02.006","article-title":"Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies","volume":"174","author":"Kobayashi","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-231395_ref57","doi-asserted-by":"crossref","first-page":"e0229860","DOI":"10.1371\/journal.pone.0229860","article-title":"Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson\u2019s disease","volume":"15","author":"Jeong","year":"2020","journal-title":"PLoS One"},{"key":"10.3233\/JAD-231395_ref58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2015.07.025","article-title":"123I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"357","author":"Kim","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-231395_ref59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.parkreldis.2005.12.008","article-title":"Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson\u2019s disease correlate with major autonomic symptoms?","volume":"12","author":"Matsui","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-231395_ref60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12883-020-01928-5","article-title":"Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson\u2019s disease and de novo dementia with Lewy bodies","volume":"20","author":"Oka","year":"2020","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-231395_ref61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00702-023-02633-6","article-title":"The brain-first vs. body-first model of Parkinson\u2019s disease with comparison to alternative models","volume":"130","author":"Borghammer","year":"2023","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-231395_ref62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JPD-230001","article-title":"Dopaminergic dysfunction is more symmetric in dementia with Lewy bodies compared to Parkinson\u2019s disease","volume":"13","author":"Fedorova","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-231395_ref63","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.24717","article-title":"(123) I-2\u03b2-carbomethoxy-3\u03b2-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: A comparative study","volume":"80","author":"Tiraboschi","year":"2016","journal-title":"Ann Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-231395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:58:24Z","timestamp":1777370304000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-231395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":63,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-231395","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}